EARLY DETECTION OF PANCREATIC DUCTAL ADENOCARCINOMA: CURRENT STRATEGIES AND EMERGING APPROACHES

Authors

  • Esankulova B.S. Samarkand State Medical University Author

Keywords:

Keywords: pancreatic cancer, early detection, biomarkers, surveillance, CA 19-9, liquid biopsy

Abstract

Pancreatic ductal adenocarcinoma (PDAC) accounts for roughly 90% of pancreatic malignancies and remains one of the most lethal solid tumors, with a five-year survival rate of about 13%. Its poor prognosis is largely due to late diagnosis: fewer than one in five patients have surgically resectable disease at presentation, because early-stage tumors rarely cause specific symptoms.

 

Downloads

Published

2026-10-15